Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) (C-Term) Peptide

Details for Product No. ABIN1382186
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms C9orf12, RGD1311271, rIpk1, RIP, RIP1, D330015H01Rik, Rinp, Rip1, 2400006N03Rik, RP23-83I13.5, Rip
Protein Region
C-Term
Origin
Human
(2), (1)
Application
Blocking Peptide (BP)
Pubmed 1 reference available
Quantity 0.05 mg
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN1382186
77.00 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 14 amino acids near the carboxy terminus of human RIP1.
Human
Alternative Name RIP1
Research Area Immunology, Innate Immunity, Apoptosis/Necrosis
Application Notes RIP1 peptide is used for blocking the activity of RIP1 antibody. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37 °C.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Stanger, Leder, Lee et al.: "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death." in: Cell, Vol. 81, Issue 4, pp. 513-23, 1995 (PubMed).

Validation Images
back to top